NYSE: ASHAshland Inc Stock
$50.48+0.93 (+1.88%)
Updated Apr 17, 2025
ASH Price
$50.48
Fair Value Price
N/A
Market Cap
$2.38B
52 Week Low
$45.21
52 Week High
$102.50
P/E
-84.13x
P/B
0.92x
P/S
1.65x
PEG
N/A
Dividend Yield
2.42%
Revenue
$2.05B
Earnings
-$23.00M
Gross Margin
30.9%
Operating Margin
-14.13%
Profit Margin
-1.1%
Debt to Equity
1.02
Operating Cash Flow
$184M
Beta
0.96
Next Earnings
Apr 28, 2025
Ex-Dividend
N/A
Next Dividend
N/A
ASH Overview
Ashland Global Holdings Inc. provides additives and specialty ingredients to pharmaceutical companies and manufacturers of personal care products, food, and beverages, paint, coatings, and construction materials. Its Valvoline segment sells automotive lubricants and chemicals and operates a chain of repair shops and quick lube oil change stores under the Valvoline brand. The company also sells plastic resins to automotive suppliers and electronics producers. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, DE.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ASH's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
C
ASH
Ranked#45 of 54
Ranked#45 of 54
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $31.58 | A | |
| $43.39 | B | |
| $9.81 | B |
Be the first to know about important ASH news, forecast changes, insider trades & much more!
ASH News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ASH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ASH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ASH is good value based on its book value relative to its share price (0.92x), compared to the US Specialty Chemicals industry average (3.12x)
P/B vs Industry Valuation
ASH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more ASH due diligence checks available for Premium users.
Valuation
ASH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-84.13x
Industry
27.18x
Market
27.98x
ASH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.92x
Industry
3.12x
ASH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ASH's financial health
Profit margin
Revenue
$405.0M
Net Income
-$165.0M
Profit Margin
-40.7%
ASH's Earnings (EBIT) of -$289.00M... subscribe to Premium to read more.
Interest Coverage Financials
ASH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.2B
Liabilities
$2.6B
Debt to equity
1.02
ASH's short-term assets ($1.07B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ASH's long-term liabilities ($2.21B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ASH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ASH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$40.0M
Investing
-$18.0M
Financing
-$22.0M
ASH's operating cash flow ($184.00M)... subscribe to Premium to read more.
Debt Coverage Financials
ASH vs Specialty Chemical Stocks
Ashland Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.